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Abstract
Background: The incidence of intraoperative awareness with explicit recall is 1-2/1000 cases in
the United States. The Bispectral Index monitor is an electroencephalographic method of assessing
anesthetic depth that has been shown in one prospective study to reduce the incidence of
awareness in the high-risk population. In the B-Aware trial, the number needed to treat in order
to prevent one case of awareness in the high-risk population was 138. Since the number needed to
treat and the associated cost of treatment would be much higher in the general population, the
efficacy of the Bispectral Index monitor in preventing awareness in all anesthetized patients needs
to be clearly established. This is especially true given the findings of the B-Unaware trial, which
demonstrated no significant difference between protocols based on the Bispectral Index monitor
or minimum alveolar concentration for the reduction of awareness in high risk patients.
Methods/Design: To evaluate efficacy in the general population, we are conducting a prospective,
randomized, controlled trial comparing the Bispectral Index monitor to a non-
electroencephalographic gauge of anesthetic depth. The total recruitment for the study is targeted
for 30,000 patients at both low and high risk for awareness. We have developed a novel algorithm
that is capable of real-time analysis of our electronic perioperative information system. In one arm
of the study, anesthesia providers will receive an electronic page if the Bispectral Index value is >60.
In the other arm of the study, anesthesia providers will receive a page if the age-adjusted minimum
alveolar concentration is <0.5. Our minimum alveolar concentration algorithm is sensitive to both
inhalational anesthetics and intravenous sedative-hypnotic agents.
Discussion: Awareness during general anesthesia is a persistent problem and the role of the
Bispectral Index monitor in its prevention is still unclear. The Michigan Awareness Control Study
is the largest prospective trial of awareness prevention ever conducted.
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Intraoperative awareness with explicit recall (AWR) is a
complication feared by both patients and clinicians alike.
In 2004 the Joint Commission on Accreditation of Hospi-
tal Organizations issued a Sentinel Alert in order to pro-
mote greater attention to the problem [1]. A multi-center
study in the United States by Sebel et al [2] estimated an
incidence of awareness with explicit recall of approxi-
mately 0.13%, which is consistent with European studies
[3]. A proportion of patients experiencing AWR may sub-
sequently develop serious psychological sequelae, includ-
ing post-traumatic stress disorder (PTSD) [4,5]. As such, a
reliable and practical method of preventing AWR would
be an important clinical advance.
The Bispectral Index (BIS) monitor has been proposed as
a method of assessing adequate depth of anesthesia and is
based on electroencephalography (EEG) analysis of burst
suppression, spectral power of the beta bandwidth, and
bispectral coherence [6,7]. The proprietary algorithm of
the BIS combines these features and expresses the depth of
anesthesia by a dimensionless number ranging from 100
(fully awake) to 0 (isoelectric). The BIS monitor has been
validated in a number of studies assessing both anesthetic
drug concentrations and level of sedation [7-9].
Ekman et al [10] prospectively studied 4945 patients who
were to receive general endotracheal anesthesia with neu-
romuscular blockade. These patients were monitored with
the BIS, with values recommended between 40 and 60.
The incidence of AWR in this population was 0.04%,
compared with 0.18% in a historical control group of
7826 patients from a previous study of awareness in
which no cerebral function monitoring was used. The
incidence of 0.04% in this cohort represented 2 patients,
both of whom had BIS values of 60 for 4 minutes or more.
Myles et al [11] completed a prospective, randomized
study of BIS-guided anesthetic management of patients at
high risk for awareness. Postoperative interviews identi-
fied 2 patients (0.16%) who experienced confirmed AWR
in the BIS-guided group compared to 11 (0.9%) in the
control group. One patient with awareness had an epi-
sode during which the BIS had reached approximately 80,
whereas the other had a period in which the BIS reached
55-59. Collectively, these studies suggested the potential
for the BIS to reduce the incidence of intraoperative
awareness. A more recent study by Avidan et al [12] in the
high risk population suggested that a protocol to increase
vigilance, rather than the BIS monitor itself, could possi-
bly account for the reduction in the incidence of aware-
ness. They found no statistically significant difference
between a BIS-guided and minimum alveolar concentra-
tion (MAC)-guided protocol.
Assuming the BIS can reduce the incidence of AWR, the
number needed to treat in order to avoid one case of
awareness in the high-risk population was 138, with an
associated cost of approximately US$2200 in 2004 [11].
The number needed to treat and its associated cost would
thus rise considerably in the general population. Further-
more, if one considers the total number of awareness
reports ("possible" plus "confirmed"), there was no differ-
ence between the BIS and routine care groups in the B-
Aware trial. Therefore, the clear efficacy of BIS monitoring
in the general surgical population would need to be estab-
lished before recommending it as a general practice, espe-
cially given the results of the B-Unaware trial. This is the
basis for conducting the prospective and randomized
Michigan Awareness Control Study (MACS).
Methods/Design
Ethics
We have received Institutional Review Board approval
from the University of Michigan Medical School.
Calculating Sample Size
Sample size was based on an incidence of AWR of 1-2
cases/1000, in agreement with the studies of Sebel et al [2]
and Sandin et al [3]. To compare an incidence of intraop-
erative awareness of approximately 0.15% using conven-
tional management versus a 0.04% incidence rate with BIS
monitoring (a rate based on Ekman et al [10]), we calcu-
late a need for 14,072 per group or a total n = 28,144 with
an 80% power. Given the potential for missing data or
patient non-compliance, we will target at least 30,000
patients for the current study. Based on our current
recruitment rate, we estimate that in approximately 36
months we can realistically achieve this sample size at our
institution.
Assessing the Incidence of Awareness
We are assessing the presence of AWR at 28-30 days. Given
the extremely large number of patients to be interviewed,
we chose only one interview time point. Interviewers
blinded to the study conditions conduct the modified
Brice interview [13], which is defined by the following
questions:
1. What was the last thing you remember before going
to sleep?
2. What is the first thing you remember after waking
up?
3. Do you remember anything between going to sleep
and waking up?
4. Did you dream during your procedure?Page 2 of 6
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Based on the data obtained from these interviews, any
reports suggestive of awareness are investigated and classi-
fied by a committee blinded to the study conditions.
Awareness reports are classified as:
1. No awareness, or awareness of something with a
high probability of occurring in the immediate preop-
erative or postoperative period.
2. Possible awareness: patient unable to recall any
event definitively indicative of awareness.
3. Definite awareness in which events are confirmed or
have a high likelihood of occurring in the intraopera-
tive period.
Any patients with possible or definite awareness are fol-
lowed by the primary anesthesiologist, as well as the
Quality Assurance division of our department. Psychiatric
care is formally offered by Quality Assurance representa-
tives to all patients with possible or definite awareness.
Events are also classified according to the Michigan
Awareness Classification Instrument, which has been
shown to have excellent inter-observer agreement
(Appendix 1) [14].
Comparing the BIS-guided and MAC-guided electronic 
alerts for the prevention of awareness under general 
anesthesia
We anticipate approximately 30,000 participants over 36
months of study who satisfy the following criteria:
Inclusion
• >18 years of age
• Competent to give informed consent
• Available for follow-up
Exclusion
• Adhesive allergy
• Surgery involving the forehead
• Psychosis or memory impairment
• History of brain injury
• History of electroencephalographic abnormality
(e.g., epilepsy or congenital low-voltage EEG)
BIS monitors that do not have independent displays have
been introduced into the monitoring modules of adult
operating rooms at the University of Michigan (University
Hospital, Cardiovascular Center, East Ann Arbor outpa-
tient surgery center). We obtain informed consent from
eligible patients undergoing surgery in these rooms, then
apply the BIS Quattro sensor to the left forehead accord-
ing to manufacturer instructions. Myles et al [11] and Avi-
dan et al [12] have already conducted prospective studies
of patients traditionally considered to be at high risk for
awareness. Since the risk factors for AWR are still not com-
pletely understood--and since it is important to evaluate
the efficacy of the BIS monitor in the general population-
-we are including all surgical patients receiving general
anesthesia, regardless of the perceived risk.
The University of Michigan Health System utilizes the
Centricity electronic perioperative information system in
all of its operating rooms, as well as the post-anesthesia
care unit. Using this system, automated real-time analysis
of BIS values or MAC levels is possible, with the output of
electronic alphanumeric alerts if certain criteria are not
met. The most common preventable cause of AWR is
insufficient levels of anesthesia [15]. Although MAC and
MAC-awake are well known to vary with age and surgical
procedure [16], it can be argued that <0.5 age-adjusted
MAC is approaching the level where consciousness may
return (i.e., MAC-awake) [17]. Operating rooms are rand-
omized to either (1) electronic alerts in the event of BIS
values >60, or (2) electronic alerts for age-adjusted MAC-
level of <0.5. In addition to the standard inhalational
anesthetics, the "effective MAC" level also incorporates
documented propofol infusions, dexmedetomidine infu-
sions, and boluses of propofol, sodium thiopental, etomi-
date, or ketamine (Appendix 2) [18]. Alerts state the BIS
value or MAC level, followed by "Potentially insufficient
anesthesia- please check vaporizers and intravenous
lines." The clinicians electronically signed into the case
also have the option of suspending the alerting system for
a period of 30 minutes after at least 2 pages regarding
potentially insufficient anesthesia have been generated. In
order to do this, they must electronically enter a reason for
suspending pages (such as stimulus-appropriate anes-
thetic, emergence, etc).
In the BIS-targeted rooms, BIS values appear on the main
monitoring screen and are automatically recorded. In the
MAC alert-targeted rooms, BIS values will neither appear
on the monitor nor be immediately accessible. Other
aspects of anesthetic care (e.g., choice of anesthetic
agents) are not standardized for this study. Consistent
with other studies of awareness and BIS monitoring, the
use of benzodiazepines is not standardized.Page 3 of 6
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total events of AWR during general anesthesia will be cal-
culated based on the data acquisition described above.
Subsequently, the individual cases will be appropriately
categorized based on whether they were in the BIS or MAC
group, allowing statistical comparison of the incidence of
awareness (definite awareness, possible awareness, aggre-
gate) in the two randomized groups. An interim analysis
by an independent data monitoring group will be per-
formed after 20,000 patients have been recruited. Asym-
metric stopping boundaries will be designed to allow
early termination of the trial if the use of BIS-guided alerts
is found to reduce AWR or if there is a low probability that
the trial can demonstrate a lower AWR rate in the BIS-alert
group than in the MAC-alert group (futility stopping
rule).
Secondary Outcomes
Other studies will be conducted based on the data gath-
ered at the University of Michigan, including:
• Comparison of Quality Assurance and prospective
assessments of awareness incidence using data from
the University of Michigan.
• Incidence of post-traumatic stress disorder (PTSD) in
patients with definite or possible AWR.
• Predictors of PTSD based on the classification of the
awareness event.
• Incidence and type of dreams during anesthesia in
conjunction with MAC or BIS values.
• The relationship of cumulative time with BIS <45 (as
well as other BIS thresholds), anesthetic doses, and
mortality.
• Relationship between BIS values and hemodynamic
parameters.
• Analysis of interrupted monitoring during the use of
the BIS.
• Reasons for the purposeful administration of light
anesthesia.
• Efficacy of MAC-based alerts in cases with exclusively
inhalational anesthesia compared with those includ-
ing intravenous infusions.
• BIS values and anesthetic dosing of chronic pain
patients.
• Changes in overall use of anesthetics before and after
the introduction of alerts.
• Overall use of anesthetics comparing the BIS to MAC
alerts.
• Postanesthesia care unit pain scores, neurologic
exam, and discharge time in relationship to BIS values.
• Incidence of post-operative nausea and vomiting in
relationship to BIS values.
Discussion
Awareness during general anesthesia continues to be an
important challenge for the anesthesiologist and a source
of major distress for the patient. The BIS monitor is the
only processed EEG monitor that has been shown to
reduce awareness in a prospective study, but its successful
use for the prevention of awareness in the general surgical
population has not yet been investigated. MACS is the first
prospective, randomized, controlled trial of the BIS mon-
itor and awareness that includes all awareness risk levels
and incorporates intravenous agents in a MAC-based pro-
tocol. It will also prospectively test other novel methods
for the prevention or study of awareness, such as the
Michigan Awareness Classification Instrument and an
electronic algorithm based on both MAC and intravenous
agents.
In conjunction with the ongoing BAG-RECALL study, as
well as the prior B-Unaware study, we will conduct pre-
specified meta-analyses of approximately 38,000 patients
prospectively studied at 4 institutions. This will be espe-
cially important for the assessment of relatively rare out-
comes such as mortality or PTSD. Furthermore, since
MACS will also include the high-risk population, we will
be able to select high-risk patients who received only inha-
lational anesthesia in order to compare the 0.7 age-
adjusted MAC threshold (BAG-RECALL) and the 0.5 age-
adjusted MAC threshold (MACS). This will be an impor-
tant study in assessing critical anesthetic levels for risk of
awareness. Collectively, the analysis of data from both
MACS and BAG-RECALL has the potential for signifi-
cantly advancing the field of awareness research.
Abbreviations
AWR: Awareness with Explicit Recall; BIS: Bispectral
Index; EEG: Electroencephalography; MAC: Minimum
Alveolar Concentration; MACS: Michigan Awareness Con-
trol Study; PTSD: Post-traumatic Stress Disorder.
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Appendix 1: Michigan Awareness Classification 
Instrument
Class 0: No awareness
Class 1: Isolated auditory perceptions
Class 2: Tactile perceptions (e.g., surgical manipulation or
endotracheal tube)
Class 3: Pain
Class 4: Paralysis (e.g., feeling one cannot move, speak, or
breathe)
Class 5: Paralysis AND pain
An additional designation of "D" for distress was also
included for patient reports of fear, anxiety, suffocation,
sense of doom, sense of impending death, etc.
Appendix 2: Electronic Algorithm for the 
Detection of Potentially Insufficient Anesthesia
• Conditions for an "active case" are:
1. data capture is possible (i.e., not a paper record)
2. data capture is active (i.e., "patient in room" has
been electronically entered and end-tidal [Et] CO2
is detected)
3. case has been identified as a general anesthetic
4. "anesthesia induction end" has already been
documented
5. request for recovery room bed or transport to an
intensive care unit has not been documented
6. surgical dressing completion has not been doc-
umented
• The alerting system checks the most recent value
(within a specified time period) of:
1. Et Sevoflurane (MAC = 2.0)
2. Et Isoflurane (MAC = 1.2)
3. Et Desflurane (MAC = 6)
4. Et Nitrous Oxide (MAC = 105)
and compares it to the MAC of each agent. It adds the
resulting MAC values together for "current total MAC."
• The system then checks for a charted propofol infu-
sion in mcg/kg/min and divides by 150, assuming that
150 mcg/kg/min is "1.0 MAC" for propofol. The anal-
ogous concept of MAC for propofol is "Cp50"- the
plasma or blood concentrations at which 50% of
patients do not move in response to a noxious stimu-
lus. Since we do not have the technology at our insti-
tution to calculate Cp50 or Cp50-awake, we have
chosen the above propofol dose as an initial value
based on clinical experience. The resultant MAC
equivalent is added to current total MAC. (For further
discussion, see [18].)
• The system next checks for a dexmedetomidine infu-
sion with a rate of 0.2 mcg/kg/hour or greater. If
present, it multiplies the current total inhalational
MAC by 2, as dexmedetomidine can reduce MAC by
50% [19].
• At this point, the "current total MAC" is defined as:
Et Sevo/2 + Et Iso/1.2 + Et Des/6 + Et Nitrous/105 +
propofol rate (in mcg/kg/min)/150. If dexmedetomi-
dine is ≥ 0.2 mcg/kg/hour, inhalational MAC is multi-
plied by 2.
• If this total MAC is below a set threshold, the system
assesses whether a bolus of propofol, midazolam, eto-
midate, or thiopental has been documented in the
preceding 10 minutes.
• The system then triggers an alert if total age-adjusted
MAC is below the assigned threshold AND no bolus
has been documented in the preceding 10 minutes.
Age adjustment for MAC is only performed for volatile
agents and is based on calculations derived from prior
literature [16,20].
• If implemented, the clinician electronically signed
into the case receives an alphanumeric page stating
"Potentially insufficient anesthesia, please check
vaporizers and intravenous lines."
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